Abstract
With λs estimates of 10 to 20 and other evidence of familial aggregation, as well as a monozygotic twin concordance rate >20, systemic lupus erythematosus (SLE) would appear to be a very promising phenotype using modern genetic approaches. Indeed, genetic associations are already known at numerous candidate loci including various HLA alleles, complement component genes, Fcγ receptors, and others, and murine genetic studies of lupus models have provided additional candidate genes and potential syntenic linkages to evaluate in man. The completed genetic linkage studies performed on various collections of pedigrees multiplex for SLE have identified 60 susceptibility loci with varying degrees of evidence for linkage in man. Seven of these meet or exceed the threshold for significant linkage (LOD ⩾ 3.3 or P ⩽ 0.00005) at 1q22–23, 1q41, 2q37, 4p16, 6p21–11, 16q13 and 17p13. In addition, these linkages usually dominate in one ethnicity or another, suggesting that the responsible polymorphisms, once identified, will also vary by ethnicity. Evidence that these linkages can be reproduced range from outright independent confirmation (1q41, 4p16 and 6p21) to additional suggestive evidence in the genomic region of the purported linkage (1q22–23 and 2q37). The results now available suggest that human lupus genetics are robust and that gene identification should be possible using existing genetic approaches and technologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hochberg MC . The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois’ LupusErythematosus Williams and Wilkins: Baltimore 1997 49–65
Fessel WJ . Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women Arch Intern Med 1974 134: 1027–1035
Kaslow RA, Masi AT . Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States Arthritis Rheum 1978 21: 473–479
Lawrence RC, Helmick CG, Arnett FC et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States Arthritis Rheum 1998 41: 778–799
Hochberg MC . The application of genetic epidemiology to systemic lupus erythematosus J Rheumatol 1987 14: 867–869
Sestak AL, Shaver TS, Moser KL, Neas BR, Harley JB . Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree J Rheumatol 1999 26: 1495–1499
Vyse TJ, Todd JA . Genetic analysis of autoimmune disease Cell 1996 85: 311–318
Deapen D, Escalante A, Weinrib L et al. A revised estimate of twin concordance in systemic lupus erythematosus Arthritis Rheum 1992 35: 311–318
Arnett FC . The Genetics of Human Lupus. In: Wallace DJ, Hahn BH (eds) Dubois’ Lupus Erythematosus Williams and Wilkins: Baltimore 1997 77–117
Duits AJ, Bootsma H, Derksen RH et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients Arthritis Rheum 1995 39: 1832–1836
Salmon JE, Ng S, Yoo DH, Kim TH, Kim SY, Song GG . Altered distribution of Fcgamma receptor IIIA alleles in a cohort of Korean patients with lupus nephritis Arthritis Rheum 1999 42: 818–819
Salmon JE, Millard S, Schachter LA et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans J Clin Invest 1996 97: 1348–1354
Wu J, Edberg JC, Redecha PB et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease J Clin Invest 1997 100: 1059–1070
Bowness P, Davies KA, Norsworthy PJ et al. Hereditary C1q deficiency and systemic lupus erythematosus Q J Med 1994 87: 455–464
Ratnoff WD . Inherited deficiencies of complement in rheumatic diseases Rheum Dis Clin North Am 1996 22: 75–94
Schur PH . Complement and systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois’ Lupus Erythematosus Williams and Wilkins: Baltimore 1997 245–261
Walport MJ, Lachmann PJ . Complement deficiencies and abnormalities of the complement system in systemic lupus erythematosus and related disorders Curr Opin Rheumatol 1990 2: 661–663
Drake CG, Babcock SK, Palmer E, Kotzin BL . Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1mice Proc Natl Acad Sci USA 1994 91: 4062–4066
Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL . Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner J Immunol 1995 154: 2441–2447
Haywood ME, Hogarth MB, Slingsby JH et al. Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice Arthritis Rheum 2000 43: 349–355
Hogarth MB, Slingsby JH, Allen PJ et al. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice J Immunol 1998 161: 2753–2761
Kono DH, Burlingame RW, Owens DG et al. Lupus susceptibility loci in New Zealand mice Proc Natl Acad Sci USA 1994 91: 10168–10172
Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK . Polygenic control of susceptibility to murine systemic lupus erythematosus Immunity 1994 1: 219–229
Morel L, Tian XH, Croker BP, Wakeland EK . Epistatic modifiers of autoimmunity in a murine model of lupus nephritis Immunity 1999 11: 131–139
Vidal S, Kono DH, Theofilopoulos AN . Loci predisposing to autoimmunity in MRL-Faslprand C57BL/6-Faslprmice J Clin Invest 1998 101: 696–702
Vyse TJ, Rozzo SJ, Drake CG, Izui S, Kotzin BL . Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand Black mice J Immunol 1997 158: 5566–5574
Lander E, Kruglyak L . Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results Nat Genet 1995 11: 241–247
Bias WB, Reveille JD, Beaty TH, Meyers DA, Arnett FC . Evidence that autoimmunity in man is a Mendelian dominant trait Am J Hum Genet 1986 39: 584–602
Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families Proc Natl Acad Sci USA 1998 95: 14875–14879
Gaffney PM, Ortmann WA, Selby SA et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families Am J Hum Genet 2000 66: 547–556
Gray-McGuire C, Moser KL, Gaffney PM et al. Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16–15.2 Am J Hum Genet 2000 67: 1460–1469
Lindqvist AK, Steinsson K, Johanneson B et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q J Autoimmun 2000 14: 169–178
Moser KL, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees Proc Natl Acad Sci USA 1998 95: 14869–14874
Shai R, Quismorio FP Jr, Li L et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families Hum Mol Genet 1999 8: 639–644
Tsao BP, Cantor RM, Kalunian KC et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus J Clin Invest 1997 99: 725–731
Nath SK, Kelly JA, Namjou B et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus Am J Hum Genet 2001 69: 1401–1406
Tiwari JL, Terasaki PI . HLA-DR and disease associations Prog Clin Biol Res 1981 58: 151–163
Grumet FC, Coukell A, Bodmer JG, Bodmer WF, McDevitt HO . Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease N Engl J Med 1971 285: 193–196
Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC . Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus Arthritis Rheum 1982 25: 1031–1040
Celada A, Barras C, Benzonana G, Jeannet M . Increased frequency of HLA-DRw3 in systemic lupus erythematosus Tissue Antigens 1980 15: 283–288
Gladman KK, Urowitz MB, Darlinkton GA . Disease expression and class II HLA antigens in systemic lupus erythematosus Lupus 1999 8: 466–470
Hashimoto H, Tsuda H, Matsumoto T et al. HLA antigens associated with systemic lupus erythematosus in Japan J Rheumatol 1985 12: 919–923
Kachru RB, Sequeira W, Mittal KK, Siegel ME, Telischi M . A significant increase of GLA-DR3 and DR2 in systemic lupus erythematosus among blacks J Rheumatol 1984 11: 471–474
Kawai T, Katoh K, Tani K, Okuda K, Okubo T . HLA antigens in Japanese patients with central nervous system lupus Tissue Antigens 1990 35: 45–46
Mehra NK, Pande I, Taneja V et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in northern India Lupus 1993 2: 313–314
Reinertsen JL, Klippel JH, Johnson AH, Steinberg AD, Decker JL, Mann DL . B-lymphocyte alloantigens associated with systemic lupus erythematosus N Engl J Med 1978 299: 515–518
Reinharz D, Tiercy JM, Mach B, Jeannet M . Absence of DRw15/3 and DRw15/7 heterozygotes in Caucasian patients with systemic lupus erythematosus Tissue Antigens 1991 37: 10–15
Reveille JD, Barger BO, Hodge TW . HLA-DR2-DRB1 allele frequencies in DR2-positive black Americans with and without systemic lupus erythematosus Tissue Antigens 1991 38: 178–180
Scherak O, Smolen JS, Mayr WR . HLA-DRw3 and systemic lupus erythematosus Arthritis Rheum 1980 23: 954–957
So AK, Fielder AH, Warner CA, Isenberg DA, Batchelor JR, Walport MJ . DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus Tissue Antigens 1990 35: 144–147
Yen JH, Chen CJ, Tsai WC, Tsai JJ, Ou TT, Liu HW . HLA-DMA and HLA-DMB genotyping in patients with systemic lupus erythematosus J Rheumatol 1999 26: 1930–1933
Harley JB, Moser KL . Genetics of lupus. In: Klippel JH, Dieppe PA (eds) Rheumatology Mosby: London 1998 7.3.1–6
Awdeh ZL, Raum D, Yunis EJ, Alper CA . Extended HLA/complement allele haplotypes: evidence or T/t-like complex in man Proc Natl Acad Sci USA 1983 80: 259–263
Carroll MC, Palsdottir A, Belt KT, Porter RR . Deletion of complement C4 and 21-hydroxylase genes in the HLA class II region EMBO J 1995 4: 2547–2552
Whittingham S, Mathews JD, Schanfield MS, Tait BD, Mackay IR . HLA and Gm genes in systemic lupus erythematosus Tissue Antigens 1983 21: 50–57
Kameda S, Naito S, Tanak et al. HLA antigens of patients with systemic lupus erythematosus in Japan Tissue Antigens 1982 20: 221–222
Reveille JD, Moulds JM, Arnett FC . Major histocompatibility complex class II and C4 alleles in Mexican Americans withsystemic lupus erythematosus Tissue Antigens 1995 45: 91–97
Hawkins BR, Wong KL, Wong RW, Chan KH, Dunckley H, Serjeantson SW . Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese J Rheumatol 1987 14: 1128–1131
Arnett FC, Moulds JM . HLA class III molecules and autoimmune rheumatic diseases Clin Exp Rheumatol 1991 9: 289–296
Petri M, Watson R, Winkelstein J, McLean RH . Clinical expression of systemic lupus erythematosus in patients with C4 deficiency Medicine 1993 72: 236–244
Naves M, Hajeer AH, Teh LS et al. Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population Eur J Immunogenet 1998 25: 317–320
Hartung K, Baur MP, Coldewey R et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus: Results of a multicenter study J Clin Invest 1992 90: 1346–1351
Cornillet P, Pennaforte JL, Philbert F et al. Complement C4a gene deletion in patients with systemic lupus erythematosus in France J Rheumatol 1993 20: 1633–1634
Steinsson K, Jonsdottir S, Arason GJ et al. A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland Ann Rheum Dis 1998 57: 503–505
Sullivan KE, Kim NA, Goldman D, Petri MA . C4A deficiency due to a 2 bp insertion is increased in patients with systemic lupus erythematosus J Rheumatol 1999 26: 2144–2147
Frank MM . Complement in disease: inherited and acquired complement deficiencies In: Frank MM, Austen KF, Claman HN et al(eds) Samter’s Immunologic Diseases Little, Brown: Boston 1995 pp 489–500
Sullivan KE, Petri MA, Schmeckpeper BJ, McLean RH, Winkelstein JA . Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus J Rheumatol 1994 21: 1128–1133
Ruddy S . Component deficiencies. 3. The second component Prog Allergy 1986 39: 250–260
Truson L eds Sturfelt G, Nived O . Prevalence of the type I complement C2 deficiency gene in Swedish systemic lupus erythematosus patients Lupus 1993 2: 325–327
Walport MJ . Complement deficiency and disease Br J Rheumatol 1993 32: 269–273
Lipsker DM, Schreckenberg-Gilliot C, Uring-Lambert B et al. Lupus erythematosus associated with genetically determined deficiency of the second component of the complement Arch Dermatol 2000 136: 1508–1514
Provost TT, Arnett FC, Reichlin M . Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies Arthritis Rheum 1983 26: 1279–1282
Topaloglu R, Bakkaloglu A, Slingsby JH et al. Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency Clin Exp Rheumatol 2000 18: 75–77
Reid KBM . Deficiency of the first component of human complement. In: Rosen FS, Seligmann M (eds) Immunodeficiencies Harwood Academic Publishers: Philadelphia 1993 283–293
Salmon JE, Edberg JC, Brogle NL, Kimberly RP . Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB: independent mechaniams for differences in human phagocyte function J Clin Invest 1992 89: 1274–1281
Oh M, Petri MA, Kim NA, Sullivan KE . Frequency of the Fc gamma RIIIA-158F allele in African American patients with systemic lupus erythematosus J Rheumatol 1999 26: 1486–1489
Dijstelbloem HM, Bijl M, Fijnheer R et al. Fc gamma receptor polymorphisms in systemic lupus erythematosus. Association with disease and in vivoclearance of immune complexes Arthritis Rheum 2000 43: 2793–2800
Manger K, Repp R, Spriewald et al. Fcγ receptor IIa polymorphism in Caucasian patients with systemic lupuserythematosus Arthritis Rheum 1998 41: 1181–1189
Smyth LJ, Snowden N, Carthy D, Papasteriades C, Hajeer A, Ollier WE . Fc gamma RIIa polymorphism in systemic lupus erythematosus Ann Rheum Dis 1997 56: 744–746
Botto M, Theodoridis E, Thompson EM et al. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease Clin Exp Immunol 1996 104: 264–268
Radeke HH, Gessner JE, Uciechowski P, Magert HJ, Schmidt RE, Resch K . Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain J Immunol 1994 153: 1281–1292
Koene HR, Kleijer M, Swaak AJG et al. The Fc gamma RIIIA-159F allele is a risk factor for systemic lupus erythematosus Arthritis Rheum 1998 41: 1813–1818
Werner G, von dem Borne AE, Bos MJE et al. Localization of the human NA1 allogen on neutrophils to Fc gamma receptors In Reinherz EL, Haynes BF, Nadler LM, Bernstein ID (eds) Leukocyte Typing II, Volume 3 Springer-Verlag: New York 1985 pp 109–121
Edberg JC, Redecha PB, Salmon JE, Kimberly RP . Human Fc gamma Receptor III (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells J Immunol 1989 143: 1642–1649
Ory PA, Goldstein IM, Kwoh EE, Clarkson SB . Characterization of polymorphic forms of Fc receptor III on human neutrophils J Clin Invest 1989 83: 1676–1681
Ory PA, Clark MR, Kwoh EE, Clarkson SB, Goldstein IM . Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils J Clin Invest 1989 84: 1688–1691
Ravetch JV, Perussia B . Alternative membrane forms of Fc gamma receptor III (CD16) on human natural killer cells and neutrophils J Exp Med 1989 170: 481–497
Salmon JE, Edberg JC, Kimberly RP . Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities J Clin Invest 1990 85: 1287–1295
Clark MR, Liu L, Clarkson SB, Ory PA, Goldstein IM . An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus J Clin Invest 1990 86: 341–346
Enenkel B, Jung D, Frey J . Molecular basis of IgG Fc receptor III defect in a patient with systemic lupus erythematosus Eur J Immunol 1991 21: 659–663
Hatta Y, Tsuchiya N, Ohashi J et al. Association of Fc gamma receptor IIIB, but not Fc gamma receptor IIA and IIIA, ploymorphims with systemic lupus erythematosus in Japanese Genes Immun 1999 1: 53–60
Mehrian R, Quismorio FP, Strassman G et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus Arthritis Rheum 1998 41: 596–602
Ahmed S, Ihara K, Kanemitsu S et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population Rheumatology 2001 40: 662–667
Tebib JG, Alcocer-Varela J, Alarcon-Segovia D, Schur PH . Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus J Clin Invest 1990 86: 1961–1967
Stevens A, Ray D, Alansari A et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus Arthritis Rheum 2001 44: 2358–2366
Wilson AG, Gordon C, diGiovine FS et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha Eur J Immunol 1994 24: 191–195
Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J . Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE) Genes Immun 2001 2: 363–366
Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K . Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus Tissue Antigens 1999 53: 527–533
Rousset F, Garcia E, Defrance T et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes Proc Natl Acad Sci USA 1992 89: 1890–1893
Hagiwara E, Gourley MF, Lee S, Klinman DK . Disease severity in patients with systemic lupus erythematosus correlates with an increased ration of IL-10: IFN gamma-secreting cells in the peripheral blood Arthritis Rheum 1996 39: 379–385
Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I . Cytokine production, serum levels and disease activity in systemic lupus erythematosus Clin Exp Rheumatol 2000 18: 565–570
Csiszar A, Nagy G, Gergely P, Pozsonyi T, Pocsik E . Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) Clin Exp Immunol 2000 122: 464–470
Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M . Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice J Exp Med 1994 179: 305–310
Eskdale J, Kube D, Tesch H, Gallagher G . Mapping of the human IL10 gene and further characterization of the 5’ flanking sequence Immunogenetics 1997 46: 120–128
Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G . Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus Tissue Antigens 1997 49: 635–639
D’Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P . Systemic lupus erythematosus candidate genes in Italian population: evidence for a significant association with interleukin-10 Arthritis Rheum 2000 43: 120–128
Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 1992 356: 314–317
Takahashi T, Tanaka M, Brannan CI et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the fas ligand Cell 1994 76: 969–976
Horiuchi T, Nishizaka H, Yasunaga S et al. Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese Rheumatology 1999 38: 516–520
Lee YH, Kim YR, Ji JD, Sohn J, Song GG . Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus J Rheum 2001 28: 2008–2011
Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD . Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease J Clin Invest 1996 98: 1107–1113
Kojima T, Horiuchi T, Nishizaka H et al. Analysis of Fas ligand gene mutation in patients with systemic lupus erythematosus Arthritis Rheum 2000 43: 135–139
Turner MW . Mannose-binding lectin: the pluripotent molecule of the innate immune system Immunol Today 1996 17: 532–540
Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ . cDNA cloning and primary structure analysis of C1qRP, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro Immunity 1997 6: 1119–1129
Matsushita M, Fujita T . Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease J Exp Med 1992 176: 1497–1502
Thiel S, Vorup-Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement Nature 1997 386: 506–510
Sumiya M, Super M, Tabona P, Arai T, Turner MW, Summerfield JA . Molecular basis of opsonic defect in immunodeficient children Lancet 1991 337: 1569–1570
Lipscombe RJ, Sumiya M, Hill AVS et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene Hum Mol Genet 1992 1: 709–715
Madsen HO, Garred P, Kurtzhals JA et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein Immunogenetics 1994 40: 37–40
Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein J Immunol 1995 155: 3013–3020
Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus Arthritis Rheum 1999 42: 2145–2152
Davies EJ, Teh LS, Ordi-Ros J et al. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population J Rheumatol 1997 24: 485–488
Sullivan KE, Wooten C, Goldman D, Petri M . Mannose-binding protein polymorphism in black patients with systemic lupus erythematosus Arthritis Rheum 1996 39: 2046–2051
Ip WK, Chan SY, Lau CS, Lau YL . Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene Arthritis Rheum 1998 41: 1663–1668
Theofilopoulos AN, Dixon FJ . Murine models of systemic lupus erythematosus Adv Immunol 1985 37: 269–390
Rozzo SJ, Allard JD, Choubey D et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus Immunity 2001 14: 435–443
Mohan C, Alas E, Morel L, Yang P, Wakeland EK . Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes J Clin Invest 1998 101: 1362–1372
Mohan C, Morel L, Yang P, Wakeland EK . Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity J Immunol 1997 159: 454–465
Mohan C, Yu Y, Morel L, Yang P, Wakeland EK . Genetic dissection of SLE pathogenesis: Sle3on murine chromosome 7 impacts T cell activation, differentiation, and cell death J Immunol 1999 162: 6492–6502
Morel L, Tian XH, Croker BP, Wakeland EK . Epistatic modifiers of autoimmunity in a murine model of lupus nephritis Immunity 1999 11: 131–139
Morel L, Croker BP, Blenman KR et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains Proc Natl Acad Sci USA 2000 97: 6670–6675
Wakeland EK, Wandstrat AE, Liu K, Morel L . Genetic dissection of systemic lupus erythematosus Curr Opin Immunol 1999 11: 701–707
Morel L, Blenman KR, Croker BP, Wakeland EK . The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes Proc Natl Acad Sci USA 2001 98: 1787–1792
Cohen PL, Eisenberg RA . Lpr and gld: single gene models of systemic autoimmunity and lymphoprolifitive disease Annu Rev Immunol 1991 9: 243–269
Watson ML, Rao JK, Gilkeson GS et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci J Exp Med 1992 176: 1645–1656
Murphy ED, Roths JB . New inbred strains Mouse News Lett 1978 58: 51–52
Murphy ED, Roths JB . A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation Arthritis Rheum 1979 22: 1188–1194
Moser KL, Gray-McGuire C, Kelly J et al. Confirmation of genetic linkage between human systemic lupus erythematosus and chromosome 1q41 Arthritis Rheum 1999 42: 1902–1907
Tsao BP, Cantor RM, Grossman JM et al. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus J Clin Invest 1999 103: 1135–1140
Delrieu O, Michel M, Frances C et al. Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders Arthritis Rheum 1999 42: 2194–2197
Criswell LA, Moser KL, Gaffney PM et al. PARP alleles and SLE: failure to confirm association with disease susceptibility J Clin Invest 2000 105: 1501–1502
Graham RR, Langefeld CD, Gaffney PM et al. Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus Arthritis Res 2001 3: 299–305
Tsao BP, Grossman JM, Arnett FC et al. Investigation of SLE-linked regions identified by genome scans: support for 1q24, 16q13, and 20p12 Arthritis Rheum 2000 43.) (Suppl.): 278
Magnusson V, Lindqvist AK, Castillejo-Lopez C et al. Fine mapping of the SLEB2 locus involved in susceptibility tosystemic lupus erythematosus Genomics 2000 70: 307–314
Rao S, Olson JM, Moser KL et al. Linkage analysis of human systemic-lupus-erythematosus-related traits: a principal-component approach Arthritis Rheum 2001 44: 2807–2818
Goldin LR, Chase GA, Wilson AF . Regional inference with averaged P values increases the power to detect linkage Genet Epidermiol 1999 17: 157–164
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by grants from the National Institutes of Health (AR42460, AI24717, AR45231, AI31585, HG01577 and RR03655).
Rights and permissions
About this article
Cite this article
Kelly, J., Moser, K. & Harley, J. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 3 (Suppl 1), S71–S85 (2002). https://doi.org/10.1038/sj.gene.6363885
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363885
Keywords
This article is cited by
-
Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis
Clinical and Experimental Medicine (2022)
-
Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients
Egyptian Rheumatology and Rehabilitation (2021)
-
Serum/plasma homocysteine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis
Clinical Rheumatology (2020)
-
C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels
Clinical Rheumatology (2017)
-
TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study
Rheumatology International (2016)